✦ LIBER ✦

PUK16 COST-EFFECTIVENESS OF VALGANCICLOVIR 200 DAYS PROPHYLAXIS VERSUS 100 DAYS PROPHYLAXIS IN KIDNEY TRANSPLANT PATIENTS AT HIGH-RISK FOR DEVELOPING CYTOMEGALOVIRUS DISEASE

✍ Scribed by C. Vicente; A. Humar; C. Lemieux; R. Zilbershtein; P. Douglas; L. Formica; C. Piwko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Efficacy and Safety of 200 Days Valg

✍ A. Humar; Y. Lebranchu; F. Vincenti; E. A. Blumberg; J. D. Punch; A. P. Limaye; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

PIN56 Cost-Effectiveness Model to Evalua

✍ C. Fernández-Rivera; J. Torre-Cisneros; L. Guirado-Perich; I. Oyagüez; E. Ruiz-b 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PIN83 Cost-Effectiveness and Cost-Utilit

✍ P. Kawalec; P. Holko; M. Boratynska; M. Glyda; E. Ignacak; M. Russel-Szymczyk; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Regarding: Humar et al. The Efficacy and

✍ C. da Cunha-Bang; M. Iversen; S. A. Mortensen; A. Rasmussen; H. Sengeløv; S. S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB